Jeffrey Harrison, Ph.D. has received a two-year award from the Ocala Royal Dames for Cancer Research to conduct research on “Combining CXCR4, VEGFR and TRFβR inhibitors to synergistically inhibit GBM progression”.
Jeffrey Harrison, Ph.D. has received a two-year award from the Ocala Royal Dames for Cancer Research to conduct research on “Combining CXCR4, VEGFR and TRFβR inhibitors to synergistically inhibit GBM progression”.